| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-07-04 | 2020-07-11 | 54300 |
| APO-QUINAPRIL/HCTZ | 10MG 12.5MG | TABLET | Resolved | 2021-02-12 | 2021-05-10 | 133994 |
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Resolved | 2021-11-05 | 2025-07-11 | 148883 |
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2017-09-04 | 2018-04-15 | 20891 |
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Resolved | 2019-08-07 | 2019-09-23 | 91103 |
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Resolved | 2017-11-28 | 2018-04-18 | 31022 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-07-12 | 2019-11-25 | 89167 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-08-21 | 2019-09-16 | 92032 |
| APO-QUINAPRIL/HCTZ | 20MG 25MG | TABLET | Resolved | 2020-04-13 | 2020-09-01 | 111954 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2018-11-30 | 2019-03-16 | 68245 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| TEVA-OLMESARTAN / HCTZ | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| TEVA-OLMESARTAN / HCTZ | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| TEVA-OLMESARTAN / HCTZ | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ALDACTAZIDE 25 | 25MG 25MG | TABLET | Discontinued | 2019-10-01 | 2020-04-13 | 95153 |
| ALDACTAZIDE 50 | 50MG 50MG | TABLET | Discontinued | 2019-10-01 | 2020-04-13 | 95156 |